Nutex Health, Inc. (NUTX) Comparison with companies in other sectors?

Nutex Health, Inc. has a share price of 5.56M. You can analyze Nutex Health, Inc. (NUTX) competitors across different market sectors through stock heatmaps.

What are NUTX's NET and operating margins?

Nutex Health, Inc. (NUTX) operating margin is around 0.32, and net profit margin is approximately 0.16 as of the latest reports.

In what way does NUTX's earnings per share (EPS) trend reflect its financial momentum?

Nutex Health, Inc. (NUTX) EPS is 12.35 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Nutex Health, Inc. is 7.68, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Nutex Health, Inc.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Nutex Health, Inc. like P/E which is 4.97, P/B which is 1.75, and PEG which is 58.08. Compare them with sector averages to evaluate if the stock is priced fairly.

Nutex Health, Inc.

NUTX•NASDAQ

Healthcare

Medical - Healthcare Information Services

$95.02

$-0.73(-0.77%)

Fundamental Analysis of Nutex Health, Inc. (NUTX)

Comprehensive financial metrics and ratios analysis

EPS (TTM)

$12.35

P/E Ratio

7.68

ROE

0.71%

Net Margin

0.16%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$526.74M

Shares OutstandingTotal number of shares issued

$5.56M

Book Value/ShareNet worth per share

$53.90

Revenue/ShareAnnual revenue per share

$122.41

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$12.35

Net MarginNet income as percentage of revenue

15.50%

Operating MarginOperating income as percentage of revenue

32.26%

ROEReturn on shareholders' equity

71.10%

ROAReturn on total assets

12.70%

ROCEReturn on capital employed

34.40%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$13.63

Cash/ShareCash and equivalents per share

$17.19

FCF YieldFree cash flow as percentage of market cap

13.34%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for NUTXFinancial Ratios Analysis details for NUTX are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for NUTXSector Benchmarking details for NUTX are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Nutex Health, Inc. Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Nutex Health, Inc.. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Nutex Health, Inc.'s unique business strengths and challenges.

Key Financial Metrics for Nutex Health, Inc.

For Nutex Health, Inc., essential financial indicators include EPS 12.35, PE 7.68, and ROE 0.71. These key ratios reveal insights into Nutex Health, Inc.'s profitability, valuation, and operational health. Understanding these metrics enables you to compare Nutex Health, Inc. with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Nutex Health, Inc.

Metrics like Net Margin 15.50% and ROA 12.70% shed light on how well Nutex Health, Inc. is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Nutex Health, Inc. can sustain its operations and continue growing in the future.

Valuation and Market Position of Nutex Health, Inc.

Using ratios such as P/B Ratio 1.75 and PEG Ratio 58.08, investors can assess whether Nutex Health, Inc. is appropriately valued based on its financials and growth potential. These figures, combined with Nutex Health, Inc.'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Nutex Health, Inc.

Financial health indicators, such as Debt/Equity Ratio 1.14 and Cash Flow $13.63, provide a snapshot of Nutex Health, Inc.'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Nutex Health, Inc., is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Nutex Health, Inc.

Investing in Nutex Health, Inc. based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Nutex Health, Inc. focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;